PortfoliosLab logo
IRTC vs. BSX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between IRTC and BSX is 0.56, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

IRTC vs. BSX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iRhythm Technologies, Inc. (IRTC) and Boston Scientific Corporation (BSX). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

IRTC:

0.68

BSX:

1.79

Sortino Ratio

IRTC:

1.43

BSX:

2.34

Omega Ratio

IRTC:

1.17

BSX:

1.37

Calmar Ratio

IRTC:

0.50

BSX:

2.67

Martin Ratio

IRTC:

1.83

BSX:

10.91

Ulcer Index

IRTC:

21.59%

BSX:

3.80%

Daily Std Dev

IRTC:

58.32%

BSX:

22.30%

Max Drawdown

IRTC:

-84.39%

BSX:

-89.15%

Current Drawdown

IRTC:

-48.67%

BSX:

-3.12%

Fundamentals

Market Cap

IRTC:

$4.40B

BSX:

$152.18B

EPS

IRTC:

-$3.13

BSX:

$1.37

PEG Ratio

IRTC:

0.00

BSX:

2.53

PS Ratio

IRTC:

7.11

BSX:

8.67

PB Ratio

IRTC:

50.73

BSX:

6.85

Total Revenue (TTM)

IRTC:

$618.59M

BSX:

$17.55B

Gross Profit (TTM)

IRTC:

$429.23M

BSX:

$11.79B

EBITDA (TTM)

IRTC:

-$70.28M

BSX:

$4.09B

Returns By Period

In the year-to-date period, IRTC achieves a 52.82% return, which is significantly higher than BSX's 15.17% return.


IRTC

YTD

52.82%

1M

34.98%

6M

54.95%

1Y

39.18%

5Y*

1.22%

10Y*

N/A

BSX

YTD

15.17%

1M

9.82%

6M

16.26%

1Y

39.60%

5Y*

23.63%

10Y*

19.21%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

IRTC vs. BSX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IRTC
The Risk-Adjusted Performance Rank of IRTC is 7373
Overall Rank
The Sharpe Ratio Rank of IRTC is 7575
Sharpe Ratio Rank
The Sortino Ratio Rank of IRTC is 7676
Sortino Ratio Rank
The Omega Ratio Rank of IRTC is 7373
Omega Ratio Rank
The Calmar Ratio Rank of IRTC is 7171
Calmar Ratio Rank
The Martin Ratio Rank of IRTC is 7070
Martin Ratio Rank

BSX
The Risk-Adjusted Performance Rank of BSX is 9494
Overall Rank
The Sharpe Ratio Rank of BSX is 9494
Sharpe Ratio Rank
The Sortino Ratio Rank of BSX is 9191
Sortino Ratio Rank
The Omega Ratio Rank of BSX is 9393
Omega Ratio Rank
The Calmar Ratio Rank of BSX is 9696
Calmar Ratio Rank
The Martin Ratio Rank of BSX is 9696
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

IRTC vs. BSX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for iRhythm Technologies, Inc. (IRTC) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current IRTC Sharpe Ratio is 0.68, which is lower than the BSX Sharpe Ratio of 1.79. The chart below compares the historical Sharpe Ratios of IRTC and BSX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

IRTC vs. BSX - Dividend Comparison

Neither IRTC nor BSX has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

IRTC vs. BSX - Drawdown Comparison

The maximum IRTC drawdown since its inception was -84.39%, smaller than the maximum BSX drawdown of -89.15%. Use the drawdown chart below to compare losses from any high point for IRTC and BSX. For additional features, visit the drawdowns tool.


Loading data...

Volatility

IRTC vs. BSX - Volatility Comparison

iRhythm Technologies, Inc. (IRTC) has a higher volatility of 19.44% compared to Boston Scientific Corporation (BSX) at 5.66%. This indicates that IRTC's price experiences larger fluctuations and is considered to be riskier than BSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

IRTC vs. BSX - Financials Comparison

This section allows you to compare key financial metrics between iRhythm Technologies, Inc. and Boston Scientific Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00B20212022202320242025
158.68M
4.66B
(IRTC) Total Revenue
(BSX) Total Revenue
Values in USD except per share items

IRTC vs. BSX - Profitability Comparison

The chart below illustrates the profitability comparison between iRhythm Technologies, Inc. and Boston Scientific Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

60.0%65.0%70.0%75.0%20212022202320242025
68.8%
68.8%
(IRTC) Gross Margin
(BSX) Gross Margin
IRTC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, iRhythm Technologies, Inc. reported a gross profit of 109.22M and revenue of 158.68M. Therefore, the gross margin over that period was 68.8%.

BSX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Boston Scientific Corporation reported a gross profit of 3.21B and revenue of 4.66B. Therefore, the gross margin over that period was 68.8%.

IRTC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, iRhythm Technologies, Inc. reported an operating income of -32.56M and revenue of 158.68M, resulting in an operating margin of -20.5%.

BSX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Boston Scientific Corporation reported an operating income of 921.00M and revenue of 4.66B, resulting in an operating margin of 19.8%.

IRTC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, iRhythm Technologies, Inc. reported a net income of -30.70M and revenue of 158.68M, resulting in a net margin of -19.4%.

BSX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Boston Scientific Corporation reported a net income of 674.00M and revenue of 4.66B, resulting in a net margin of 14.5%.